- Home
- PII vs CRNX Comparison
PII vs CRNX Comparison
Compare PII & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PII
- CRNX
- Stock Information
- Founded
- PII 1954
- CRNX 2008
- Country
- PII United States
- CRNX United States
- Employees
- PII N/A
- CRNX N/A
- Industry
- PII Recreational Games/Products/Toys
- CRNX Biotechnology: Pharmaceutical Preparations
- Sector
- PII Consumer Discretionary
- CRNX Health Care
- Exchange
- PII Nasdaq
- CRNX Nasdaq
- Market Cap
- PII 2.6B
- CRNX 2.8B
- IPO Year
- PII 1987
- CRNX 2018
- Fundamental
- Price
- PII $50.23
- CRNX $30.99
- Analyst Decision
- PII Hold
- CRNX Strong Buy
- Analyst Count
- PII 12
- CRNX 8
- Target Price
- PII $41.00
- CRNX $74.86
- AVG Volume (30 Days)
- PII 1.8M
- CRNX 842.6K
- Earning Date
- PII 07-29-2025
- CRNX 08-07-2025
- Dividend Yield
- PII 5.33%
- CRNX N/A
- EPS Growth
- PII N/A
- CRNX N/A
- EPS
- PII 0.71
- CRNX N/A
- Revenue
- PII $7,072,600,000.00
- CRNX $760,000.00
- Revenue This Year
- PII N/A
- CRNX $402.02
- Revenue Next Year
- PII $4.00
- CRNX $771.03
- P/E Ratio
- PII $70.92
- CRNX N/A
- Revenue Growth
- PII N/A
- CRNX N/A
- 52 Week Low
- PII $30.92
- CRNX $24.10
- 52 Week High
- PII $87.83
- CRNX $62.53
- Technical
- Relative Strength Index (RSI)
- PII 61.36
- CRNX 49.74
- Support Level
- PII $49.04
- CRNX $30.44
- Resistance Level
- PII $53.83
- CRNX $33.28
- Average True Range (ATR)
- PII 2.13
- CRNX 1.43
- MACD
- PII 0.13
- CRNX -0.05
- Stochastic Oscillator
- PII 56.36
- CRNX 43.31
About PII Polaris Inc.
Polaris designs and manufactures off-road vehicles, including all-terrain vehicles and side-by-side vehicles for recreational and utility purposes, snowmobiles, and on-road vehicles, including motorcycles, along with the related replacement parts, garments, and accessories. The firm entered the marine market after acquiring Boat Holdings in 2018, offering exposure to another segment of the outdoor lifestyle market. Polaris products are retailed through more than 2,500 dealers in North America and 1,500 international dealers as well as more than 25 subsidiaries and 90 distributors in more than 100 countries outside North America.
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.